SEC Form 4 · accession 0001209191-18-038344
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Vachon
Director
Period of report
Jun 14, 2018
Accepted (ET)
Jun 18, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 14, 2018 | S | 700 | $189.825 | D | 300 | D | |
| Common StockF3 | Jun 14, 2018 | S | 300 | $190.3833 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017.
- F2The range in prices for the transaction reported on this line was $189.25 to $190.225. The average weighted price was $189.825. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $190.25 to $190.45. The average weighted price was $190.3833. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.